Log in to save to my catalogue

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor...

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65da5079faff4a6e8dde3829f04c532d

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1

About this item

Full title

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1

Publisher

London: BioMed Central

Journal title

Cell communication and signaling, 2022-09, Vol.20 (1), p.1-96, Article 96

Language

English

Formats

Publication information

Publisher

London: BioMed Central

More information

Scope and Contents

Contents

Background The cyclin-dependent kinase 7 (CDK7) inhibitor THZ1 represses multiple cancer cells. However, its tumor-repressive efficiency in wild-type p53 breast cancer cells remains controversial. Methods We conducted various assays, including CCK8, colony formation, flow cytometry, western blotting, and lactate dehydrogenase release detection, to...

Alternative Titles

Full title

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_65da5079faff4a6e8dde3829f04c532d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65da5079faff4a6e8dde3829f04c532d

Other Identifiers

ISSN

1478-811X

E-ISSN

1478-811X

DOI

10.1186/s12964-022-00837-z

How to access this item